Search
for
Sort by
Research 871–900 of 1000+
- ANNOUNCEMENTS
- Difficulties in differential diagnosis of alopecia in the practice of dermatologists: Clinical cases
- 795 Bacteria induce skin regeneration
- Social Status May Interfere in the Prognosis of Frontal Fibrosing Alopecia in Female Patients: An Observational Study
- Nutritional factors and hair loss
- Sulforaphane mobilizes cellular defenses that protect skin against damage by UV radiation
- Protoporphyrin IX: the Good, the Bad, and the Ugly
- Aging of hair
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Clinical evaluation of alopecias using a handheld dermatoscope
- The impact of oxidative stress on hair
- Botulinum Toxin Off-Label Use in Dermatology: A Review
- How to diagnose a lipodystrophy syndrome
- Histologic features of alopecia areata other than peribulbar lymphocytic infiltrates
- Differences in Perceptions of Beauty and Cosmetic Procedures Performed in Ethnic Patients
- Skin disorders in Parkinson’s disease: potential biomarkers and risk factors
- Acquired scalp alopecia. Part I: A review
- A Practical Approach to the Diagnosis and Management of Hair Loss in Children and Adolescents
- Cutaneous Lesions in Systemic Lupus Erythematosus
- Scalp Itch: A Systematic Review
- Dermatologic manifestations of COVID‐19: a comprehensive systematic review
- Skin manifestations among<i>GATA2</i>-deficient patients
- Acne keloidalis nuchae: risk factors and associated disorders – a retrospective study
- Alopecia in Association with Malignancy: A Review
- Hair Loss in Children
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
- Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment
- Hair and Nail Relationship
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects